|
AP1255a-ev
|
Abcepta, Inc.
|
APEH [N-term] [RB18348], Rabbit Polyclonal Antibody
|
Human
|
WB
|
|
|
AP1255a
|
Abcepta, Inc.
|
APEH [N-term] [RB18348], Rabbit Polyclonal Antibody
|
Human
|
WB
|
|
|
AM2257a-ev
|
Abcepta, Inc.
|
CD74 [1267CT820.116.140.154], Mouse Monoclonal Antibody
|
Human
|
FC, WB
|
|
|
AM2257a
|
Abcepta, Inc.
|
CD74 [1267CT820.116.140.154], Mouse Monoclonal Antibody
|
Human
|
FC, WB
|
|
|
AP9466a-ev
|
Abcepta, Inc.
|
NPY2R [N-term] [RB22922], Rabbit Polyclonal Antibody
|
Human, Mouse
|
WB
|
|
|
AP9466a
|
Abcepta, Inc.
|
NPY2R [N-term] [RB22922], Rabbit Polyclonal Antibody
|
Human, Mouse
|
WB
|
|
|
AP21198a-ev
|
Abcepta, Inc.
|
NPY2R [N-term] [RB52203], Rabbit Polyclonal Antibody
|
Human, Mouse, Rat
|
WB, IHC, FC
|
|
|
AP21198a
|
Abcepta, Inc.
|
NPY2R [N-term] [RB52203], Rabbit Polyclonal Antibody
|
Human, Mouse, Rat
|
WB, IHC, FC
|
|
|
AP14238a-ev
|
Abcepta, Inc.
|
PPYR1 [N-term] [RB34259], Rabbit Polyclonal Antibody
|
Human
|
WB
|
|
|
AP14238a
|
Abcepta, Inc.
|
PPYR1 [N-term] [RB34259], Rabbit Polyclonal Antibody
|
Human
|
WB
|
|
|
AP12933C-ev
|
Abcepta, Inc.
|
SLC15A3 [Centre] [RB28120], Rabbit Polyclonal Antibody
|
Human
|
WB, IHC-P
|
|
|
AP12933C
|
Abcepta, Inc.
|
SLC15A3 [Centre] [RB28120], Rabbit Polyclonal Antibody
|
Human
|
WB, IHC-P
|
|
|
AM2207b-ev
|
Abcepta, Inc.
|
UCHL1 [C-term] [696CT2.1.4], Mouse Monoclonal Antibody
|
Human, Rat
|
IHC-P, WB
|
|
|
AM2207b
|
Abcepta, Inc.
|
UCHL1 [C-term] [696CT2.1.4], Mouse Monoclonal Antibody
|
Human, Rat
|
IHC-P, WB
|
|
|
GTX13519
|
GeneTex International Corporation
|
MATH1 (188-200), Blocking Peptide (BSA)
|
|
ELISA, WB
|
|
|
GTX27550
|
GeneTex International Corporation
|
NFkB p50, Blocking Peptide
|
|
Blocking
|
|
|
GTX28006
|
GeneTex International Corporation
|
NFkB p50, Blocking Peptide
|
|
Blocking
|
|
|
GTX32133-PEP
|
GeneTex International Corporation
|
GDPD5, Blocking Peptide for GTX32133
|
|
Blocking
|
|
|
HY-105088-10mg
|
MedChemexpress LLC
|
Pexiganan [CAS 147664-63-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-105088-5mg
|
MedChemexpress LLC
|
Pexiganan [CAS 147664-63-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-106994-10mg
|
MedChemexpress LLC
|
Nebentan [CAS 403604-85-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-106994-25mg
|
MedChemexpress LLC
|
Nebentan [CAS 403604-85-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-106994-5mg
|
MedChemexpress LLC
|
Nebentan [CAS 403604-85-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-18962A-10mg
|
MedChemexpress LLC
|
AMI-1 (free acid) [CAS 134-47-4]
|
|
Cancer-programmed cell death
|
|
|
HY-18962A-25mg
|
MedChemexpress LLC
|
AMI-1 (free acid) [CAS 134-47-4]
|
|
Cancer-programmed cell death
|
|
